NLRP3 Inflammasome Inhibitor - Proton pump inhibitor

Glybenclamide, also known as glyburide, blocks the maturation of caspase-1 and pro-IL-1β by inhibiting the K+ efflux [1]. Glybenclamide was shown to potently block the activation of the NRLP3 inflammasome induced by PAMPs, DAMPs and crystalline substances [2, 3]. Recent data suggest that glybenclamide works downstream of the P2X7 receptor but upstream of NRLP3 [2].


Working concentration: 25 μg/ml
CAS Number:
Molecular weight:
Soluble in DMSO (25 mg/ml) and ethanol (5 mg/ml)


• 1 g Glybenclamide (Glyburide)


1. Laliberte RE. et al., 1999. ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J Biol Chem. 274(52):36944-51.
2. Lamkanfi M. et al., 2009. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J. Cell Biol., 187: 61 - 70.
3. Dostert C. et al., 2009. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One. 4(8):e6510.


Recent articles using InvivoGen Glybenclamide



Description Proton pump inhibitor
Cat. Codetlrl-gly
Unit Size1 g
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "".